Compound Radar

AtriCure, Inc. (ATRC) Stock Analysis

Price $53.73
Market cap $2.73B
Next earnings Oct 27, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

45
45/100 Speculative
  • Financial Health 40
  • Profitability 85
  • Business Quality 75
  • Balance Sheet 65
  • Cash Flow 70

Why this rating?

Health 45/100 — Speculative

Strongest Profitability 85/100
Softest Financial Health 40/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

AtriCure, Inc. (ATRC) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates AtriCure, Inc. 45/100 (Speculative) due to high business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Elevated

Financial highlights

Valuation

  • P/E 255.86
  • Forward P/E 124.44
  • EV/Revenue 4.44

Profitability

  • Revenue Growth 12.8%
  • Gross Margin 76.3%
  • Operating Margin 6.3%
  • Net Margin 1.9%
  • ROE 2.2%

Financial strength

  • Cash $167.79M
  • Debt $74.22M
  • Net Cash $93.56M
  • Free Cash Flow $42.28M
  • Current Ratio 4.22

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks AtriCure, Inc. (ATRC).

View Methodology & FAQ →